DK1551849T3 - Tricyklisk tetrahydroquinolin antibakterielle midler - Google Patents

Tricyklisk tetrahydroquinolin antibakterielle midler

Info

Publication number
DK1551849T3
DK1551849T3 DK03799056.1T DK03799056T DK1551849T3 DK 1551849 T3 DK1551849 T3 DK 1551849T3 DK 03799056 T DK03799056 T DK 03799056T DK 1551849 T3 DK1551849 T3 DK 1551849T3
Authority
DK
Denmark
Prior art keywords
antibacterial agents
tricyclic tetrahydroquinoline
tricyclic
tetrahydroquinoline antibacterial
agents
Prior art date
Application number
DK03799056.1T
Other languages
Danish (da)
English (en)
Inventor
M R Barbachyn
P J Dobrowolski
A R Hurd
D J Mcnamara
John Raymond Palmer
A G Romero
James Craig Ruble
D A Sherry
L M Thomasco
P L Toogood
Gordon L Bundy
Gary E Martin
Donna L Romero
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1551849T3 publication Critical patent/DK1551849T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK03799056.1T 2002-10-07 2003-10-03 Tricyklisk tetrahydroquinolin antibakterielle midler DK1551849T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41668502P 2002-10-07 2002-10-07
US42718902P 2002-11-18 2002-11-18
US45762203P 2003-03-26 2003-03-26
PCT/IB2003/004389 WO2004031195A1 (en) 2002-10-07 2003-10-03 Tricyclic tetrahydroquinoline antibacterial agents

Publications (1)

Publication Number Publication Date
DK1551849T3 true DK1551849T3 (da) 2010-10-25

Family

ID=32074379

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03799056.1T DK1551849T3 (da) 2002-10-07 2003-10-03 Tricyklisk tetrahydroquinolin antibakterielle midler

Country Status (16)

Country Link
US (4) US7208490B2 (enExample)
EP (1) EP1551849B1 (enExample)
JP (1) JP4009652B2 (enExample)
AR (1) AR041546A1 (enExample)
AT (1) ATE473985T1 (enExample)
AU (1) AU2003264768A1 (enExample)
BR (1) BR0315139A (enExample)
CA (1) CA2500824C (enExample)
CY (1) CY1110821T1 (enExample)
DE (1) DE60333379D1 (enExample)
DK (1) DK1551849T3 (enExample)
MX (1) MXPA05002701A (enExample)
PT (1) PT1551849E (enExample)
SI (1) SI1551849T1 (enExample)
TW (1) TWI295671B (enExample)
WO (1) WO2004031195A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
JP2008543739A (ja) * 2005-05-09 2008-12-04 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 抗菌剤
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
CN101784553A (zh) * 2007-07-02 2010-07-21 阿斯利康(瑞典)有限公司 3-螺嘧啶三酮-喹啉衍生物及其作为抗菌药物的应用
RU2010105007A (ru) 2007-07-16 2011-08-27 Астразенека Аб (Se) Химические соединения
AU2009305203B2 (en) * 2008-10-14 2013-03-07 Entasis Therapeutics Limited Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
WO2010075380A1 (en) * 2008-12-23 2010-07-01 Abbott Laboratories Anti-viral compounds
BR112013001138A2 (pt) 2010-07-16 2016-07-05 Abbvie Inc ligantes de fosfina para reações catalíticas
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
WO2012009699A2 (en) 2010-07-16 2012-01-19 Abbott Laboratories Process for preparing antiviral compounds
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
RU2644250C2 (ru) * 2012-09-14 2018-02-08 Элизабет ЛЕВИНА Лекарственное средство с активностью против грамположительных бактерий, микобактерий и грибов
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
JP6156845B2 (ja) * 2014-03-04 2017-07-05 株式会社島津製作所 マトリックス支援レーザ脱離イオン化質量分析用マトリックス
EA033459B1 (ru) 2014-05-29 2019-10-31 Entasis Therapeutics Ltd Конденсированные спироциклические гетероароматические соединения для лечения бактериальных инфекций
WO2017156519A1 (en) 2016-03-11 2017-09-14 The Board Of Trustees Of The University Of Illinois Small-molecules active against gram-negative bacteria
US11274106B2 (en) 2017-06-23 2022-03-15 The Board Of Trustees Of The University Of Illinois Topoisomerase inhibitors with antibacterial and anticancer activity
CN108101860B (zh) * 2018-02-08 2021-11-23 苏州敬业医药化工有限公司 顺式-2，6-二甲基吗啉的制备方法
CN115466212B (zh) * 2022-10-26 2023-09-22 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用
CN118878546B (zh) * 2024-09-30 2025-01-03 苏州大学 一种螺环巴比妥酸衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
CA2425283A1 (en) 2000-10-26 2002-05-02 Pfizer Products Inc. Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
WO2003091252A1 (en) 2002-04-25 2003-11-06 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
MXPA05003774A (es) 2002-10-10 2005-06-08 Pharmacia & Upjohn Co Llc Compuestos de 1-aril-dihidropiridona con actividad antimicrobiana.

Also Published As

Publication number Publication date
US7605157B2 (en) 2009-10-20
AR041546A1 (es) 2005-05-18
JP4009652B2 (ja) 2007-11-21
US7208490B2 (en) 2007-04-24
SI1551849T1 (sl) 2010-11-30
ATE473985T1 (de) 2010-07-15
CA2500824C (en) 2011-03-22
US20070161630A1 (en) 2007-07-12
EP1551849A1 (en) 2005-07-13
EP1551849B1 (en) 2010-07-14
US20110092494A1 (en) 2011-04-21
CA2500824A1 (en) 2004-04-15
TWI295671B (en) 2008-04-11
BR0315139A (pt) 2005-08-09
WO2004031195A1 (en) 2004-04-15
PT1551849E (pt) 2010-09-27
US20040162279A1 (en) 2004-08-19
AU2003264768A1 (en) 2004-04-23
JP2006511595A (ja) 2006-04-06
US20100022524A1 (en) 2010-01-28
DE60333379D1 (de) 2010-08-26
CY1110821T1 (el) 2015-06-10
TW200413394A (en) 2004-08-01
US8420646B2 (en) 2013-04-16
MXPA05002701A (es) 2005-08-19

Similar Documents

Publication Publication Date Title
EP1618087A4 (en) ANTIBACTERIAL AGENTS
IS7662A (is) Ný þríhringlaga spírópíperídín eða spírópýrrólídín
ATE422495T1 (de) Antibakterielle naphthydrin- und quinolinderivate
NO20042356L (no) Tioetersubstituerte imidazokinoliner
DK1440077T3 (da) Syntetiske heparinpentasaccharider
NO20042121D0 (no) Kinolinforbindelse
ATE402148T1 (de) Substituierte pyridinylamine
AU2003300965A8 (en) Antibacterial agents
DE602004031845D1 (de) Ng
ATE354631T1 (de) Nuancierungsmittel
SI1551849T1 (sl) Triciklični tetrahidrokinolini kot antibakterijska sredstva
DE50206892D1 (de) Substituierte imidazotriazinone
NO20020621D0 (no) Antibakterielle midler
DK1373228T3 (da) Substituerede fluoralkoxyphenylsulfonylurinstoffer
DE60102936D1 (de) Antibakterielle mutiline
DE60135877D1 (de) Antibakterielle zusammensetzung
DE50213651D1 (de) Substituierte 4-aminocyclohexanole
DE602004018799D1 (de) Ng
DE60311233D1 (de) Chinolinderivate
AU2003224345A8 (en) Antibacterial agents
DE50209187D1 (de) Antibakterielle makrozyklen
DE502004009935D1 (de) Substituierte dihydrochinazoline ii
DE50209386D1 (de) Kugelgelenk
DE60216967D1 (de) Substituierte cyclohexanderivate
EP1597265A4 (en) GLYCOSYLATED ENKEPHALINE AGENTS